ArticleThe EMBO journal2025

Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis.

Rema Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.